2hwm: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2hwm.jpg|left|200px]]
{{Seed}}
[[Image:2hwm.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2hwm|  PDB=2hwm  |  SCENE=  }}  
{{STRUCTURE_2hwm|  PDB=2hwm  |  SCENE=  }}  


'''Crystal structure of Lys12Val/Cys117Val mutant of human acidic fibroblast growth factor at 1.60 angstrom resolution'''
===Crystal structure of Lys12Val/Cys117Val mutant of human acidic fibroblast growth factor at 1.60 angstrom resolution===




==Overview==
<!--
The beta-trefoil protein human fibroblast growth factor-1 (FGF-1) is made up of a six-stranded antiparallel beta-barrel closed off on one end by three beta-hairpins, thus exhibiting a 3-fold axis of structural symmetry. The N and C terminus beta-strands hydrogen bond to each other and their interaction is postulated from both NMR and X-ray structure data to be important in folding and stability. Specific mutations within the adjacent N and C terminus beta-strands of FGF-1 are shown to provide a substantial increase in stability. This increase is largely correlated with an increased folding rate constant, and with a smaller but significant decrease in the unfolding rate constant. A series of stabilizing mutations are subsequently combined and result in a doubling of the DeltaG value of unfolding. When taken in the context of previous studies of stabilizing mutations, the results indicate that although FGF-1 is known for generally poor thermal stability, the beta-trefoil architecture appears capable of substantial thermal stability. Targeting stabilizing mutations within the N and C terminus beta-strand interactions of a beta-barrel architecture may be a generally useful approach to increase protein stability. Such stabilized mutations of FGF-1 are shown to exhibit significant increases in effective mitogenic potency, and may prove useful as "second generation" forms of FGF-1 for application in angiogenic therapy.
The line below this paragraph, {{ABSTRACT_PUBMED_17570396}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17570396 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17570396}}


==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Beta-trefoil]]
[[Category: Beta-trefoil]]
[[Category: Hormone/growth factor complex]]
[[Category: Hormone/growth factor complex]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 06:48:11 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 20:01:41 2008''